FDA Approves New Animal Drug for Heartworm Treatment

Summary

The FDA is amending its regulations to reflect approval of a new animal drug application for melarsomine dihydrochloride, a treatment for heartworm disease in dogs, filed by Rhone Merieux, Inc.